Pisani, A., Riccio, E., & Sabbatini, M. (2015). Agalsidase alfa and agalsidase beta in the treatment of Fabry disease: Does the dose really matter? Genet Med.
Styl ChicagoPisani, Antonio, Eleonora Riccio, a Massimo Sabbatini. "Agalsidase Alfa and Agalsidase Beta in the Treatment of Fabry Disease: Does the Dose Really Matter?" Genet Med 2015.
Citace podle MLAPisani, Antonio, Eleonora Riccio, a Massimo Sabbatini. "Agalsidase Alfa and Agalsidase Beta in the Treatment of Fabry Disease: Does the Dose Really Matter?" Genet Med 2015.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..